These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1618 related items for PubMed ID: 22080879
41. Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells. Zhou C, Qiu L, Sun Y, Healey S, Wanebo H, Kouttab N, Di W, Yan B, Wan Y. Int J Oncol; 2006 Jul; 29(1):269-78. PubMed ID: 16773209 [Abstract] [Full Text] [Related]
42. The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process. Yu C, Rahmani M, Dai Y, Conrad D, Krystal G, Dent P, Grant S. Cancer Res; 2003 Apr 15; 63(8):1822-33. PubMed ID: 12702569 [Abstract] [Full Text] [Related]
43. [Effects of PI3K/Akt/NF-κB signal pathway on FSH facilitation on cell proliferation and invasion by human epithelial ovarian cancer]. Xu CL, Lu XL, Yan XN, Wang HL, Chen SQ. Zhonghua Fu Chan Ke Za Zhi; 2012 Feb 15; 47(2):134-8. PubMed ID: 22455747 [Abstract] [Full Text] [Related]
44. Antitumor activity and induction of TP53-dependent apoptosis toward ovarian clear cell adenocarcinoma by the dual PI3K/mTOR inhibitor DS-7423. Kashiyama T, Oda K, Ikeda Y, Shiose Y, Hirota Y, Inaba K, Makii C, Kurikawa R, Miyasaka A, Koso T, Fukuda T, Tanikawa M, Shoji K, Sone K, Arimoto T, Wada-Hiraike O, Kawana K, Nakagawa S, Matsuda K, McCormick F, Aburatani H, Yano T, Osuga Y, Fujii T. PLoS One; 2014 Feb 15; 9(2):e87220. PubMed ID: 24504419 [Abstract] [Full Text] [Related]
45. Anticancer properties of pomolic acid-induced AMP-activated protein kinase activation in MCF7 human breast cancer cells. Youn SH, Lee JS, Lee MS, Cha EY, Thuong PT, Kim JR, Chang ES. Biol Pharm Bull; 2012 Feb 15; 35(1):105-10. PubMed ID: 22223345 [Abstract] [Full Text] [Related]
46. [Effect and mechanism of LY294002 on growth of fibrosarcoma cell line HT1080]. Zhou H, Huang XY, Yang T, Wang T, Xu D, Wen FQ. Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jan 15; 41(1):20-3. PubMed ID: 20369463 [Abstract] [Full Text] [Related]
47. Blockade of fatty acid synthase induces ubiquitination and degradation of phosphoinositide-3-kinase signaling proteins in ovarian cancer. Tomek K, Wagner R, Varga F, Singer CF, Karlic H, Grunt TW. Mol Cancer Res; 2011 Dec 15; 9(12):1767-79. PubMed ID: 21970855 [Abstract] [Full Text] [Related]
48. Antitumor activity of curcumin by modulation of apoptosis and autophagy in human lung cancer A549 cells through inhibiting PI3K/Akt/mTOR pathway. Liu F, Gao S, Yang Y, Zhao X, Fan Y, Ma W, Yang D, Yang A, Yu Y. Oncol Rep; 2018 Mar 15; 39(3):1523-1531. PubMed ID: 29328421 [Abstract] [Full Text] [Related]
49. Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma. Vega F, Medeiros LJ, Leventaki V, Atwell C, Cho-Vega JH, Tian L, Claret FX, Rassidakis GZ. Cancer Res; 2006 Jul 01; 66(13):6589-97. PubMed ID: 16818631 [Abstract] [Full Text] [Related]
50. Down-regulation of Rictor enhances cell sensitivity to PI3K inhibitor LY294002 by blocking mTORC2-medicated phosphorylation of Akt/PRAS40 in esophageal squamous cell carcinoma. Hou G, Zhao Q, Zhang M, Fan T, Liu M, Shi X, Ren Y, Wang Y, Zhou J, Lu Z. Biomed Pharmacother; 2018 Oct 01; 106():1348-1356. PubMed ID: 30119206 [Abstract] [Full Text] [Related]
51. Asiatic acid exerts anticancer potential in human ovarian cancer cells via suppression of PI3K/Akt/mTOR signalling. Ren L, Cao QX, Zhai FR, Yang SQ, Zhang HX. Pharm Biol; 2016 Nov 01; 54(11):2377-2382. PubMed ID: 26984021 [Abstract] [Full Text] [Related]
52. Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cells. Yuan CX, Zhou ZW, Yang YX, He ZX, Zhang X, Wang D, Yang T, Pan SY, Chen XW, Zhou SF. Drug Des Devel Ther; 2015 Nov 01; 9():1293-318. PubMed ID: 25767376 [Abstract] [Full Text] [Related]
53. Phosphoinositide-3-kinase inhibition enhances radiosensitization of cervical cancer in vivo. Liu Y, Cui B, Qiao Y, Zhang Y, Tian Y, Jiang J, Ma D, Kong B. Int J Gynecol Cancer; 2011 Jan 01; 21(1):100-5. PubMed ID: 21330835 [Abstract] [Full Text] [Related]
54. Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells. Zakikhani M, Blouin MJ, Piura E, Pollak MN. Breast Cancer Res Treat; 2010 Aug 01; 123(1):271-9. PubMed ID: 20135346 [Abstract] [Full Text] [Related]
55. Cordycepin induces apoptosis in human bladder cancer T24 cells through ROS-dependent inhibition of the PI3K/Akt signaling pathway. Kim SO, Cha HJ, Park C, Lee H, Hong SH, Jeong SJ, Park SH, Kim GY, Leem SH, Jin CY, Hwang EJ, Choi YH. Biosci Trends; 2019 Aug 01; 13(4):324-333. PubMed ID: 31527329 [Abstract] [Full Text] [Related]
56. Zinc enhances intestinal epithelial barrier function through the PI3K/AKT/mTOR signaling pathway in Caco-2 cells. Shao Y, Wolf PG, Guo S, Guo Y, Gaskins HR, Zhang B. J Nutr Biochem; 2017 May 01; 43():18-26. PubMed ID: 28193579 [Abstract] [Full Text] [Related]
57. Inhibition of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway but not the MEK/ERK pathway attenuates laminin-mediated small cell lung cancer cellular survival and resistance to imatinib mesylate or chemotherapy. Tsurutani J, West KA, Sayyah J, Gills JJ, Dennis PA. Cancer Res; 2005 Sep 15; 65(18):8423-32. PubMed ID: 16166321 [Abstract] [Full Text] [Related]
58. Anti-Tumor Effects of Atractylenolide-I on Human Ovarian Cancer Cells. Long F, Wang T, Jia P, Wang H, Qing Y, Xiong T, He M, Wang X. Med Sci Monit; 2017 Jan 31; 23():571-579. PubMed ID: 28141785 [Abstract] [Full Text] [Related]
59. Inhibition of mitotic Aurora kinase A by alisertib induces apoptosis and autophagy of human gastric cancer AGS and NCI-N78 cells. Yuan CX, Zhou ZW, Yang YX, He ZX, Zhang X, Wang D, Yang T, Wang NJ, Zhao RJ, Zhou SF. Drug Des Devel Ther; 2015 Jan 31; 9():487-508. PubMed ID: 25609923 [Abstract] [Full Text] [Related]
60. Knockdown of DEPTOR inhibits cell proliferation and increases chemosensitivity to melphalan in human multiple myeloma RPMI-8226 cells via inhibiting PI3K/AKT activity. Zhang HR, Chen JM, Zeng ZY, Que WZ. J Int Med Res; 2013 Jun 31; 41(3):584-95. PubMed ID: 23613505 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]